| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/09/1998 | WO1998014584A2 Compositions and methods for the prevention and diagnosis of human granulocytic ehrlichiosis |
| 04/09/1998 | WO1998014582A1 Therapeutic compositions and methods for treating disease states with myeloid progenitor inhibitory factor-1 (mpif-1), monocyte colony inhibitory factor (m-cif), and macrophage inhibitory factor-4 (mip-4) |
| 04/09/1998 | WO1998014580A1 Reconstituted human anti-hm1.24 antibody |
| 04/09/1998 | WO1998014579A1 Rath genes and polypeptides and methods for the treatment and diagnosis of immune disorders |
| 04/09/1998 | WO1998014577A3 Nucleotide and protein sequence of mammastatin and methods of use |
| 04/09/1998 | WO1998014577A2 Nucleotide and protein sequence of mammastatin and methods of use |
| 04/09/1998 | WO1998014576A2 Secreted proteins and polynucleotides encoding them |
| 04/09/1998 | WO1998014573A1 Mcp-4 and mcp-5: novel chemokines |
| 04/09/1998 | WO1998014572A1 Novel human phospholemman-like protein |
| 04/09/1998 | WO1998014571A1 Human sulfonylurea receptor surh |
| 04/09/1998 | WO1998014570A1 NOVEL ATPase INHIBITOR |
| 04/09/1998 | WO1998014568A1 Human growth gene and short stature gene region |
| 04/09/1998 | WO1998014567A2 Methods and compositions for inhibiting bacterial growth |
| 04/09/1998 | WO1998014566A1 Method for obtaining microorganisms capable of producing antitumor molecules |
| 04/09/1998 | WO1998014565A1 Novel receptor that causes cell death |
| 04/09/1998 | WO1998014563A1 spsA POLYNUCLEOTIDES AND POLYPEPTIDES |
| 04/09/1998 | WO1998014480A1 G protein-coupled receptor antagonists |
| 04/09/1998 | WO1998014479A1 Method of searching for physiologically active substances and process for producing the same |
| 04/09/1998 | WO1998014478A1 Continuous low-dose administration of parathyroid hormone or its agonist |
| 04/09/1998 | WO1998014477A1 THERAPEUTIC COMPOSITIONS AND METHODS FOR TREATING DISEASE STATES WITH LEUKOCYTE ADHESION INHIBITOR-1 (LAI-1), AND CHEMOKINE BETA-11 (Ckβ-11) |
| 04/09/1998 | WO1998014476A1 Pharmaceutical compositions containing an mpl ligand |
| 04/09/1998 | WO1998014474A1 E2f activity inhibitory compounds |
| 04/09/1998 | WO1998014473A1 Colostrinin, and uses thereof |
| 04/09/1998 | WO1998014472A1 Pfs28 fusion proteins |
| 04/09/1998 | WO1998014468A1 Glycoconjugates of modified camptothecin derivatives (a- or b-ring linkage) |
| 04/09/1998 | WO1998014467A1 Method of purifying protein from inclusion bodies |
| 04/09/1998 | WO1998014464A1 Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof |
| 04/09/1998 | WO1998014461A1 NOVEL spsB |
| 04/09/1998 | WO1998014459A1 Glycoconjugates from modified camptothecin derivates (20-o-linkage) |
| 04/09/1998 | WO1998014222A1 Methods and compositions for programming an organic matrix for remodeling into a target tissue |
| 04/09/1998 | WO1998014217A1 Methods and means for the treatment of malignancies |
| 04/09/1998 | WO1998014210A1 Method for treating allergic lung disease |
| 04/09/1998 | WO1998014209A1 Oral administration of chicken yolk antibodies to treat disease |
| 04/09/1998 | WO1998014206A1 T cells mediating an immune response and methods of use |
| 04/09/1998 | WO1998014204A1 USES OF COMPOSITIONS WITH α-LACTALBUMEN BASE |
| 04/09/1998 | WO1998014203A1 A method and compositions for treatment of insulin-dependant diabetes mellitus |
| 04/09/1998 | WO1998014202A1 Regulation of neural enzymes |
| 04/09/1998 | WO1998014201A1 Method for treatment of immunodeficiency virus infection |
| 04/09/1998 | WO1998014197A1 Method of inhibiting smooth muscle cell proliferation |
| 04/09/1998 | WO1998014186A1 Substances and their uses |
| 04/09/1998 | WO1998014172A1 Inhibition of bcl-2 protein expression by liposomal antisense oligodeoxynucleotides |
| 04/09/1998 | WO1998014169A1 Methods and compounds for treatment of abnormal uterine bleeding |
| 04/09/1998 | WO1998003647A3 Use of recombinant myelin protein for treating t-cell-mediated autoimmune diseases of the peripheral nervous system |
| 04/09/1998 | WO1998001549A3 Genetic sequences and proteins related to alzheimer's disease, and uses therefor |
| 04/09/1998 | WO1998001474A3 Derivatives of somatostatin, amino acids or oligopeptides and their combination useful for promoting body growth |
| 04/09/1998 | WO1997048804A3 Tie-2 receptor ligands (tie ligand-3; tie ligand-4) and their uses |
| 04/09/1998 | WO1997047329A3 Radiopharmaceutical compositions capable of localizing at sites of thrombus |
| 04/09/1998 | WO1997045746A3 Prion protein binding proteins and uses thereof |
| 04/09/1998 | WO1997045550A3 Mini-adenoviral vector |
| 04/09/1998 | WO1997039721A3 Methods and compositions for regulating t cell subsets by modulating transcription factor activity |
| 04/09/1998 | DE19740733A1 Powder composition containing absorbent resin and peptide |
| 04/09/1998 | DE19640733A1 Polypeptide than binds to CD30 without cell activation |
| 04/09/1998 | DE19637518A1 PTX-sensitive G-Proteine, ihre Herstellung und Verwendung PTX-sensitive G-proteins, their production and use |
| 04/09/1998 | CA2647169A1 Human growth gene and short stature gene region |
| 04/09/1998 | CA2645721A1 Human telomerase reverse transcriptase |
| 04/09/1998 | CA2269079A1 Rath genes and polypeptides and methods for the treatment and diagnosis of immune disorders |
| 04/09/1998 | CA2268020A1 Uses of compositions with .alpha.-lactalbumen base |
| 04/09/1998 | CA2268013A1 Compositions and methods for the prevention and diagnosis of human granulocytic ehrlichiosis |
| 04/09/1998 | CA2267694A1 Method of inhibiting smooth muscle cell proliferation |
| 04/09/1998 | CA2267683A1 Method for treatment of immunodeficiency virus infection |
| 04/09/1998 | CA2267675A1 Method for treating allergic lung disease |
| 04/09/1998 | CA2267664A1 Human telomerase reverse transcriptase |
| 04/09/1998 | CA2267641A1 Method of purifying protein from inclusion bodies |
| 04/09/1998 | CA2267523A1 Regulation of neural enzymes |
| 04/09/1998 | CA2267493A1 Glycoconjugates of modified camptothecin derivatives (a- or b-ring linkage) |
| 04/09/1998 | CA2267421A1 Oral administration of chicken yolk antibodies to treat disease |
| 04/09/1998 | CA2267328A1 Glycoconjugates from modified camptothecin derivates (20-o-linkage) |
| 04/09/1998 | CA2267193A1 Therapeutic compositions and methods for treating disease states with myeloid progenitor inhibitory factor-1 (mpif-1), monocyte colony inhibitory factor (m-cif), and macrophage inhibitory factor-4 (mip-4) |
| 04/09/1998 | CA2267190A1 G protein-coupled receptor antagonists |
| 04/09/1998 | CA2267188A1 E2f activity inhibiting compound |
| 04/09/1998 | CA2267131A1 Therapeutic compositions and methods for treating disease states with leukocyte adhesion inhibitor-1 (lai-1), and chemokine beta-11 (ck.beta.-11) |
| 04/09/1998 | CA2267121A1 Secreted proteins and polynucleotides encoding them |
| 04/09/1998 | CA2267111A1 Methods and compositions for programming an organic matrix for remodeling into a target tissue |
| 04/09/1998 | CA2267097A1 Human growth gene and short stature gene region |
| 04/09/1998 | CA2267063A1 A method and compositions for treatment of insulin-dependant diabetes mellitus |
| 04/09/1998 | CA2266752A1 Telomerase reverse transcriptase |
| 04/09/1998 | CA2266327A1 Novel receptor that causes cell death |
| 04/09/1998 | CA2265466A1 Human sulfonylurea receptor surh |
| 04/09/1998 | CA2265449A1 Disease associated protein tyrosine phosphatases |
| 04/09/1998 | CA2265447A1 Novel human phospholemman-like protein |
| 04/09/1998 | CA2242590A1 T cells mediating an immune response and methods of use |
| 04/09/1998 | CA2237940A1 Method for obtaining microorganisms capable of producing antitumor molecules |
| 04/09/1998 | CA2236914A1 Interleukin-1.beta. converting enzyme like cysteine protease |
| 04/08/1998 | EP0834568A2 Novel saliva binding protein |
| 04/08/1998 | EP0834567A2 Compounds and methods for the diagnosis and treatment of Babesia microti infection |
| 04/08/1998 | EP0834565A2 A G-protein coupled receptor HUVCT36 |
| 04/08/1998 | EP0834564A2 A mouse genomic clone of the CC-CKR5 receptor |
| 04/08/1998 | EP0834563A2 Human 7-transmembrane receptor, member of the chemokine receptor family, named Strl-33 |
| 04/08/1998 | EP0834562A1 Polypetide exhibiting calpain inhibition activity and method for the preparation thereof |
| 04/08/1998 | EP0834556A1 Methods for culturing cells |
| 04/08/1998 | EP0834323A1 Cytokine gene therapy for treatment of malignacies |
| 04/08/1998 | EP0834321A1 Oral remedy for rheumatoid arthritis and functional food |
| 04/08/1998 | EP0834320A1 Drug composition comprising albumin as active ingredient |
| 04/08/1998 | EP0833948A1 Colon specific gene and protein |
| 04/08/1998 | EP0833941A1 Polypeptides having a functional domain of interest and methods of identifying and using same |
| 04/08/1998 | EP0833935A1 Cell line producing analgesic compounds for treating pain |
| 04/08/1998 | EP0833925A1 Diagnostic test for equine arteritis virus mediated disease |
| 04/08/1998 | EP0833924A1 Adenovirus e1a-associated protein bs69, inhibitor of e1a-transactivation |
| 04/08/1998 | EP0833921A1 ADHERENCE GENE FROM $i(HELICOBACTER PYLORI) AND POLYPEPTIDE CODED THEREBY |
| 04/08/1998 | EP0833918A1 Nucleic acid molecule and its uses in determining pathogenicity of staphylococcus |